로딩 중…
지수 로딩 중…
DAEWON PHARMACEUTICAL CO.,LTD
003220· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩8,540-2.95%
2026-06-19
Price Chart
DAEWON PHARMACEUTICAL CO.,LTD-36.36%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 191.53B KRW |
| Revenue | 605.66B KRW |
| Net Income | 10.09B KRW |
| Total Assets | 595.99B KRW |
| Net Assets | 270.98B KRW |
| Employees | 1,332 |
| Value | |
| P/E | 18.97x |
| P/B | 0.71x |
| P/S | 0.32x |
| EV/EBITDA | 633.63x |
| FCF Yield | 6.53% |
| Profitability | |
| ROE | 3.73% |
| ROA | 1.69% |
| Op. Margin | 0.14% |
| Revenue Growth | 0.14% |
| Earnings Growth | -64.60% |
| Financial Health | |
| Debt Ratio | 219.94% |
| Total Debt | 361.11B KRW |
| FCF | 12.51B KRW |
| Cash | 27.95B KRW |
| Current Ratio | 1.18x |
| Dividend | |
| Div. Yield | 2.84% |
| Div. Growth | -16.67% |
| Performance | |
| 1Y Return | -36.36% |
| 1M Return | -8.27% |
| From 52W High | -39.39% |
| 1Y MDD | -41.37% |
| Trading | |
| Volume | 132,565 shares |
| Foreign Own. | 12.99% |
| Per Share | |
| EPS | -195 KRW |
| BPS | 12,263 KRW |
Company Info
Daewon Pharmaceutical, incorporated in 1961, currently holds 11 subsidiaries, with Beijing Skinlala's liquidation expected by 2025. The company's core business involves manufacturing and selling pharmaceuticals, cosmetics, and health functional foods, supplying new drugs, incrementally modified drugs, and generic drugs to domestic medical institutions. Leveraging excellent GMP-certified production facilities and specialized products, Daewon Pharmaceutical engages in CMO business, exports finished pharmaceuticals and medical devices, and operates a health functional food business focused on Jangdaewon. The company is headquartered in Seongdong-gu, Seoul.